EPHYMAX financials
A multi-period view of the public annual-account figures reported for EPHYMAX, with comparable measures and links to available source documents.
Company overviewRegistry number
0893168278
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for EPHYMAX
2025 versus 2024
- Operating line
- €10,699
- EBITDA
- €8,703
- Total assets
- €109,403
- Equity
- €71,966
+63.3%
+121.6%
+7.1%
+7.7%
EBITDA margin +81.3% · Equity ratio +65.8%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €10,699 | €8,703 | €109,403 | €71,966 | - |
| 202431 Dec 2024 | €6,551 | €3,928 | €102,173 | €66,800 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.